# Multiple Ascending Dose Study of Miravirsen in Treatment-Naïve Chronic Hepatitis C Subjects

> **NCT01200420** · PHASE2 · COMPLETED · sponsor: **Santaris Pharma A/S** · enrollment: 38 (actual)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** miravirsen
- **DRUG:** saline

## Key facts

- **NCT ID:** NCT01200420
- **Lead sponsor:** Santaris Pharma A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2012-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01200420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01200420, "Multiple Ascending Dose Study of Miravirsen in Treatment-Naïve Chronic Hepatitis C Subjects". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01200420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*